{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:19:32Z","timestamp":1789697972431,"version":"4.0.1"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0901501"],"award-info":[{"award-number":["2016YFC0901501"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>McCune-Albright syndrome is a rare disorder characterized by fibrous dysplasia, caf\u00e9 au lait skin spots, and hyperfunctioning endocrinopathies. The coexistence of precocious puberty and growth hormone excess in McCune-Albright syndrome is rare. Both conditions can manifest as accelerated growth, and treatments can be more challenging for such patients. This study aimed to describe the clinical manifestations of combined GH excess and PP in the context of McCune-Albright syndrome and analyze the clinical features and treatments of these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Clinical data from 60 McCune-Albright syndrome patients from Peking Union Medical College Hospital were obtained. The demographic characteristics, growth hormone, insulin-like growth factor-1, prolactin, alkaline phosphatase, and sex hormone levels; growth velocity; and bone age data were obtained. The growth velocity Z-score, bone age over chronological age ratio, and predicted adult height Z-score were calculated before and after treatment. Published studies and case reports were systemically searched, and data on demographic, clinical, and biochemical characteristics and treatment outcomes were obtained.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We reviewed seven patients among 60 McCune-Albright syndrome patients at Peking Union Medical College Hospital (5 female) and 39 patients (25 female) from the published literature. Six of the seven patients from Peking Union Medical College Hospital and half of the patients from the published studies were pediatric patients. These patients had increased growth velocity Z-scores and bone age over chronological age ratios. After good control of both conditions, the growth velocity Z-score and bone age over chronological age ratio decreased significantly, and the predicted adult height Z-score increased. The final heights and predicted adult height Z-scores were not impaired in patients with gigantism. All the patients had craniofacial fibrous dysplasia associated with optic and otologic complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>McCune-Albright syndrome with growth hormone excess and precocious puberty is more common in girls. Patients have accelerated linear growth and advanced skeletal age, and early and good control of both conditions leads to a reduced growth velocity and stabilized bone age. The predicted adult and final heights are not negatively affected when growth hormone excess is diagnosed in pediatric patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.672394","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T06:57:15Z","timestamp":1635490635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Characteristics and Management of Patients With McCune-Albright Syndrome With GH Excess and Precocious Puberty: A Case Series and Literature Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiao","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous Dysplasia\/McCune-Albright Syndrome: A Rare, Mosaic Disease of G\u03b1\u200as Activation","volume":"41","author":"Boyce","year":"2020","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating Mutations of the Stimulatory G Protein in the McCune\u2013Albright Syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM193704292161701","article-title":"Syndrome Characterized by Osteitis Fibrosa Disseminata, Areas of Pigmentation and Endocrine Dysfunction, With Precocious Puberty in Females: Report of Five Cases","volume":"216","author":"Albright","year":"1937","journal-title":"New Engl J Med"},{"key":"B4","volume-title":"Fibrous Dysplasia\/Mccune-Albright Syndrome","author":"Boyce","year":"2019"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00522","article-title":"Auxological and Endocrinological Features in Children With McCune Albright Syndrome: A Review","volume":"11","author":"Tufano","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","volume-title":"McCune Albright Syndrome. StatPearls","author":"Holbrook","year":"2021"},{"key":"B7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-3-12","article-title":"McCune-Albright Syndrome","volume":"3","author":"Dumitrescu","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1750-1172-7-S1-S4","article-title":"McCune-Albright Syndrome and the Extraskeletal Manifestations of Fibrous Dysplasia","volume":"7","author":"Collins","year":"2012","journal-title":"Orphanet J rare Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0012","article-title":"Prevalence and Incidence of Precocious Pubertal Development in Denmark: An Epidemiologic Study Based on National Registries","volume":"116","author":"Teilmann","year":"2005","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1515\/jpem.1998.11.1.77","article-title":"Secondary Central Precocious Puberty in a Girl With McCune-Albright Syndrome Responds to Treatment With GnRH Analogue","volume":"11","author":"Schmidt","year":"1998","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1987.tb10576.x","article-title":"Precocious Puberty in the McCune-Albright Syndrome. Progression From Gonadotrophin-Independent to Gonadotrophin-Dependent Puberty in a Girl","volume":"76","author":"Pasquino","year":"1987","journal-title":"Acta Paediatr Scand"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00337","article-title":"Peculiarities of Precocious Puberty in Boys and Girls With McCune-Albright Syndrome","volume":"9","author":"Corica","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","volume-title":"Treatment of Peripheral Precocious Puberty. Puberty From Bench to Clinic","author":"Schoelwer","year":"2016"},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-16-0715","article-title":"Clinical Characteristics and Management of Growth Hormone Excess in Patients With McCune-Albright Syndrome","volume":"176","author":"Yao","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2001-012022","article-title":"Characterization of Gsp-Mediated Growth Hormone Excess in the Context of McCune-Albright Syndrome","volume":"87","author":"Akintoye","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3826","article-title":"Acromegaly and McCune-Albright Syndrome","volume":"99","author":"Salenave","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2111","article-title":"Optic Neuropathy in McCune-Albright Syndrome: Effects of Early Diagnosis and Treatment of Growth Hormone Excess","volume":"98","author":"Boyce","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cen.13722","article-title":"Growth Hormone\u2014Insulin-Like Growth Factor 1 Axis Hyperactivity on Bone Fibrous Dysplasia in McCune-Albright Syndrome","volume":"89","author":"Tessaris","year":"2018","journal-title":"Clin Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2017.2407","article-title":"Association of Hearing Loss and Otologic Outcomes With Fibrous Dysplasia","volume":"144","author":"Boyce","year":"2018","journal-title":"JAMA Otolaryngol\u2013Head Neck Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/odi.12563","article-title":"Fibrous Dysplasia of Bone: Craniofacial and Dental Implications","volume":"23","author":"Burke","year":"2017","journal-title":"Oral Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2174\/1573405616666201209102418","article-title":"Craniofacial Fibrous Dysplasia Involvements of Mccune-Albright Syndrome: A Review With an Additional Case","volume":"17","author":"\u00d6zcan","year":"2020","journal-title":"Curr Med Imaging"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115661","article-title":"Optic Disc Edema in Fibrous Dysplasia\/McCune-Albright Syndrome: Prevalence, Etiologies, and Clinical Implications","volume":"143","author":"Raborn","year":"2021","journal-title":"Bone"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185561","article-title":"Reference Ranges for Serum Insulin-Like Growth Factor I (IGF-I) in Healthy Chinese Adults","volume":"12","author":"Zhu","year":"2017","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K09E-200","article-title":"Reference Ranges for Serum IGF-1 and IGFBP-3 Levels in Chinese Children During Childhood and Adolescence","volume":"57","author":"Xu","year":"2010","journal-title":"Endocr J"},{"key":"B25","volume-title":"Reproductive Endocrinology, Surgery, and Technology","author":"Adashi","year":"1996"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1097\/00000441-195909000-00030","volume-title":"Radiographic Atlas of Skeletal Development of the Hand and Wrist","author":"Greulich","year":"1959"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(52)80205-7","article-title":"Tables for Predicting Adult Height From Skeletal Age. Revised for Use With the Greulich-Pyle Hand Standards","volume":"40","author":"Bayley","year":"1952","journal-title":"J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1310.2009.07.003","article-title":"Height and Weight Standardized Growth Charts for Chinese Children and Adolescents Aged 0 to 18 Years","volume":"47","author":"Li","year":"2009","journal-title":"Zhonghua er ke za zhi= Chin J Pediatr"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1310.2009.05.017","article-title":"General Growth Patterns and Simple Mathematic Models of Height and Weight of Chinese Children","volume":"47","author":"Zong","year":"2009","journal-title":"Zhonghua er ke za zhi= Chin J Pediatr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO Growth Reference for School-Aged Children and Adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-9455.2009.13.026","article-title":"Reference Values of Serum Alkaline Phosphatase for Chinese Children and Adolescents Aged 0 to 18 Years","volume":"6","author":"Lu","year":"2009","journal-title":"Clinics Lab Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-229141","article-title":"McCune Albright Syndrome: An Endocrine Medley","volume":"12","author":"Rajan","year":"2019","journal-title":"BMJ Case Rep CP"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0000000000005498","article-title":"Surgical Treatment of Polyostotic Craniomaxillofacial Fibrous Dysplasia Associated With Acromegalia: The McCune\u2013Albright Syndrome","volume":"30","author":"Franco","year":"2019","journal-title":"J\u00a0Craniofacial Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13419","article-title":"Long-Term Health Outcomes of Adults With McCune-Albright Syndrome","volume":"87","author":"Wong","year":"2017","journal-title":"Clin Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-2661","article-title":"Pegvisomant for the Treatment of Gsp-Mediated Growth Hormone Excess in Patients With McCune-Albright Syndrome","volume":"91","author":"Akintoye","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1274","article-title":"Somatic GNAS Mutation Causes Widespread and Diffuse Pituitary Disease in Acromegalic Patients With McCune-Albright Syndrome","volume":"97","author":"Vortmeyer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1752-1947-6-32","article-title":"Pamidronic Acid and Cabergoline as Effective Long-Term Therapy in a 12-Year-Old Girl With Extended Facial Polyostotic Fibrous Dysplasia, Prolactinoma and Acromegaly in McCune-Albright Syndrome: A Case Report","volume":"6","author":"Classen","year":"2012","journal-title":"J Med Case Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1750-1172-6-67","article-title":"Sporadic and Genetic Forms of Paediatric Somatotropinoma: A Retrospective Analysis of Seven Cases and a Review of the Literature","volume":"6","author":"Nozi\u00e8res","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0461-9","article-title":"McCune\u2013Albright Syndrome: Surgical and Therapeutic Challenges in GH-Secreting Pituitary Adenomas","volume":"104","author":"Madsen","year":"2011","journal-title":"J Neuro-Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302009000100015","article-title":"McCune-Albright Syndrome and Acromegaly: Hormonal Control With Use of Cabergoline and Long-Acting Somatostatin-Case Report","volume":"53","author":"Almeida","year":"2009","journal-title":"Arquivos Brasileiros Endocrinologia Metabologia"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.0048","article-title":"McCune-Albright Syndrome With Acromegaly and Fibrous Dysplasia Associated With the GNAS Gene Mutation Identified by Sensitive PNA-Clamping Method","volume":"46","author":"Imanaka","year":"2007","journal-title":"Internal Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0561","article-title":"McCune-Albright Syndrome and Acromegaly: Effects of Hypothalamopituitary Radiotherapy and\/or Pegvisomant in Somatostatin Analog-Resistant Patients","volume":"91","author":"Galland","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.14310\/horm.2002.11186","article-title":"A Boy With McCune-Albright Syndrome Associated With GH Secreting Pituitary Microadenoma. Clinical Findings and Response to Treatment","volume":"5","author":"Papadopoulou","year":"2006","journal-title":"Hormones-Athens-"},{"key":"B44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1515\/JPEM.2005.18.1.33","article-title":"Paediatric Management of Endocrine Complications in McCune-Albright Syndrome","volume":"18","author":"Zacharin","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2001.14.5.553","article-title":"Clinical, Endocrinological and Radiological Features in a Child With McCune-Albright Syndrome and Pituitary Adenoma","volume":"14","author":"Zumkeller","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.11.8923825","article-title":"Gs Alpha Mutation at Codon 201 in Pituitary Adenoma Causing Gigantism in a 6-Year-Old Boy With McCune-Albright Syndrome","volume":"81","author":"D\u00f6tsch","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.4.7714111","article-title":"Growth Hormone Hypersecretion in a Girl With McCune-Albright Syndrome: Comparison With Controls and Response to a Dose of Long-Acting Somatostatin Analog","volume":"80","author":"Feuillan","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02272.x","article-title":"Acromegaly and Its Treatment in the McCune-Albright Syndrome","volume":"36","author":"Premawardhana","year":"1992","journal-title":"Clin Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349592","article-title":"Acromegaly, Multinodular Goiter and Silent Polyostotic Fibrous Dysplasia, A Variant of the McCune\u2014Albright Syndrome","volume":"13","author":"Abs","year":"1990","journal-title":"J Endocrinological Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-198907000-00026","article-title":"Pituitary Adenoma in McCune-Albright Syndrome: MR Demonstration","volume":"13","author":"O'Laughlin","year":"1989","journal-title":"J Comput Assisted Tomography"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-6-1148","article-title":"Hypersecretion of Growth Hormone and Prolactin in McCune-Albright Syndrome","volume":"68","author":"Cuttler","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80258-5","article-title":"Treatment of Acromegaly With a Somatostatin Analog in a Patient With McCune-Albright Syndrome","volume":"111","author":"Geffner","year":"1987","journal-title":"J\u00a0Pediatr"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.112S207","article-title":"The McCune-Albright Syndrome","volume":"113","author":"Mauras","year":"1986","journal-title":"Eur J Endocrinol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00689340","article-title":"Mammosomatotroph Hyperplasia Associated With Acromegaly and Hyperprolactinemia in a Patient With the McCune-Albright Syndrome","volume":"403","author":"Kovacs","year":"1984","journal-title":"Virchows Archiv A"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1981.tb00632.x","article-title":"Abnormal Hypothalamic-Pituitary Function in Polyostotic Fibrous Dysplasia","volume":"14","author":"Albin","year":"1981","journal-title":"Clin Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(75)80906-1","article-title":"Growth Hormone Excess and Sexual Precocity in Polyostotic Fibrous Dysplasia (McCune-Albright Syndrome): Evidence for Abnormal Hypothalamic Function","volume":"87","author":"Lightner","year":"1975","journal-title":"J Pediatr"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1964.03860070086008","article-title":"Polyostotic Fibrous Dysplasia and Acromegaly","volume":"114","author":"Scurry","year":"1964","journal-title":"Arch Internal Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1979.tb11264.x","article-title":"Hyperprolactinaemia In A Patient With The Mccune-Albright Syndrome","volume":"86","author":"Carr","year":"1979","journal-title":"BJOG: Int J Obstetrics Gynaecol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and Incidence of Pituitary Adenomas: A Population Based Study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly Incidence, Prevalence, Complications and Long-Term Prognosis: A Nationwide Cohort Study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of Pituitary Adenomas: A Community-Based, Cross-Sectional Study in Banbury (Oxfordshire, Uk)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2007.20.6.653","article-title":"An Update on the Treatment of Precocious Puberty in McCune-Albright Syndrome and Testotoxicosis","volume":"20","author":"Haddad","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.10.1729","article-title":"Skeletal Involvement in Female Acromegalic Subjects: The Effects of Growth Hormone Excess in Amenorrheal and Menstruating Patients","volume":"12","author":"Scillitani","year":"1997","journal-title":"J Bone Miner Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041111","article-title":"An Instrument to Measure Skeletal Burden and Predict Functional Outcome in Fibrous Dysplasia of Bone","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940301)73:5<1411::AID-CNCR2820730516>3.0.CO;2-T","article-title":"Malignancies in Fibrous Dysplasia","volume":"73","author":"Ruggieri","year":"1994","journal-title":"Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"079","DOI":"10.1055\/s-2003-40597","article-title":"Osteosarcoma of the Skull Base After Radiation Therapy in a Patient With McCune-Albright Syndrome: Case Report","volume":"13","author":"Hansen","year":"2003","journal-title":"Skull Base"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2011.178","article-title":"A Case of McCune-Albright Syndrome Associated With Pituitary GH Adenoma: Therapeutic Process and Autopsy","volume":"24","author":"Fuyi","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","first-page":"136","DOI":"10.17458\/per.vol15.2017.nau.treatmentgirlsboys","article-title":"Treatment of Girls and Boys With McCune-Albright Syndrome With Precocious Puberty\u2013Update 2017","volume":"15","author":"Neyman","year":"2017","journal-title":"Pediatr Endocrinol reviews: PER"},{"key":"B70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0889-8529(18)30288-3","article-title":"Gonadotropin-Lndependent Precocious Puberty","volume":"20","author":"Holland","year":"1991","journal-title":"Endocrinol Metab Clinics North Am"},{"key":"B71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1515\/JPEM.1998.11.1.77","article-title":"Central Precocious Puberty in a Girl With McCune-Albright Syndrome Responds to Treatment With GnRH Analogue","volume":"11","author":"Schmidt","year":"1998","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.672394\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T06:57:26Z","timestamp":1635490646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.672394\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":71,"alternative-id":["10.3389\/fendo.2021.672394"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.672394","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"article-number":"672394"}}